Source: International Congress 2016 – Exploring mechanisms in health and disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Emanuel Citgez (Wierden, Netherlands), Emanuel Citgez, Job van der Palen, Paul van der Valk, Marjolein Brusse-Keizer. Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD. Eur Respir J 2016; 48: Suppl. 60, 3444

Member's Comments

No comment yet.

Related content which might interest you: BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013